Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | +24 |
| Ticker | PYC |
| Latest Price | 1.28 XXX as of close on 04-Jul-2025 |
| 3 Month price range | 0.98 to 1.32 XXX |
| Market Capitalisation | 758.24Mn XXX |
| Country | Australia |
| Region | Asia |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. The company offers VP-001, a drug program which is Phase 1 clinical trial for the treatment of retinitis pigmentosa type 11; PYC-001, a drug candidate for the treatment of blinding eye disease; PYC-002 a drug program for the treatment of a severe neurodevelopmental disorder; and PYC-003, which is indicated to treat autosomal dominant polycystic kidney disease. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia. See More ... |
| Company URL | https://pyctx.com |
| See Darwins Full Analysis for PYC Therapeutics Ltd |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for PYC Therapeutics Ltd. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +30 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -1 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -5 |
There are 2 live alerts for PYC Therapeutics Ltd. All the alerts are negative.
There are 12 peers of PYC Therapeutics Ltd.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Argenica Therapeutics Ltd (AGN) | Biotechnology | -2.0 | +22 |
| Arovella Therapeutics Ltd (ALA) | Biotechnology | +19.2 | +2 |
| CSL Ltd (CSL) | Biotechnology | -2.1 | +19 |
| Clinuvel Pharmaceuticals Ltd (CUV) | Biotechnology | -1.9 | +7 |
| Imugene Ltd (IMU) | Biotechnology | -23.7 | -9 |
| Mesoblast Ltd (MSB) | Biotechnology | -7.9 | -10 |
| Opthea Ltd (OPT) | Biotechnology | 0 | -12 |
| Paradigm Biopharmaceuticals Ltd (PAR) | Biotechnology | +49.2 | +18 |
| Polynovo Ltd (PNV) | Biotechnology | -9.1 | +2 |
| Race Oncology Ltd (RAC) | Biotechnology | -0.4 | -9 |
| Telix Pharmaceuticals Ltd (TLX) | Biotechnology | -11.9 | +7 |
| Tissue Repair Ltd (TRP) | Biotechnology | +16.2 | -10 |
To see complete information on PYC Therapeutics Ltd or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |